Simultaneous FDG-PET/MRI detects hippocampal subfield metabolic differences in AD/MCI.

Scientific Reports
Mackenzie L CarlsonMichael M Zeineh

Abstract

The medial temporal lobe is one of the most well-studied brain regions affected by Alzheimer's disease (AD). Although the spread of neurofibrillary pathology in the hippocampus throughout the progression of AD has been thoroughly characterized and staged using histology and other imaging techniques, it has not been precisely quantified in vivo at the subfield level using simultaneous positron emission tomography (PET) and magnetic resonance imaging (MRI). Here, we investigate alterations in metabolism and volume using [18F]fluoro-deoxyglucose (FDG) and simultaneous time-of-flight (TOF) PET/MRI with hippocampal subfield analysis of AD, mild cognitive impairment (MCI), and healthy subjects. We found significant structural and metabolic changes within the hippocampus that can be sensitively assessed at the subfield level in a small cohort. While no significant differences were found between groups for whole hippocampal SUVr values (p = 0.166), we found a clear delineation in SUVr between groups in the dentate gyrus (p = 0.009). Subfield analysis may be more sensitive for detecting pathological changes using PET-MRI in AD compared to global hippocampal assessment.

References

Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Jul 11, 2001·Neurobiology of Aging·S De SantiJ Fowler
Mar 21, 2002·Acta Neuropathologica·Marcus RösslerThomas G Ohm
May 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Scott A SmallCarol A Barnes
May 29, 2004·Neurobiology of Aging·Bärbel SchönheitThomas G Ohm
May 10, 2006·Archives of Neurology·Liana G ApostolovaPaul M Thompson
Jan 16, 2007·Neurobiology of Aging·Lisa MosconiMony J de Leon
Nov 8, 2008·Brain : a Journal of Neurology·Giovanni B FrisoniPaul M Thompson
Oct 13, 2009·Computer Methods and Programs in Biomedicine·Marc ModatSébastien Ourselin
Oct 23, 2009·Neurology·C A RajiJ T Becker
Feb 9, 2010·Nature Reviews. Neurology·Giovanni B FrisoniPaul M Thompson
Sep 15, 2010·Human Brain Mapping·Susanne G MuellerMichael W Weiner
Jun 15, 2011·Archives of Neurology·Raymond Y LoUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jan 18, 2012·NeuroImage·Bruce Fischl
Dec 20, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Suleman Surti
Oct 24, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Tetsuro SekineGeoffrey Warnock
Dec 19, 2015·Human Brain Mapping·Maged GoubranAli R Khan
Feb 18, 2016·EJNMMI Physics·S VandenbergheJ S Karp
Aug 27, 2016·Journal of Magnetic Resonance Imaging : JMRI·Brendan G SantyrAli R Khan
Jan 1, 2017·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David H AdamowiczFred H Gage
Oct 27, 2017·Journal of Healthcare Engineering·Serena MontiMarco Aiello
Oct 28, 2017·Journal of Healthcare Engineering·Serena MontiMarco Aiello
May 3, 2019·Journal of Neurotrauma·Sherveen N ParivashMichael Zeineh
Jun 30, 2019·Alzheimer's Research & Therapy·Ya-Nan OuUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Aug 10, 2019·IEEE Transactions on Radiation and Plasma Medical Sciences·Matthew G Spangler-BickellFloris Jansen

❮ Previous
Next ❯

Citations

Aug 3, 2021·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Mackenzie L CarlsonMichael M Zeineh

❮ Previous
Next ❯

Software Mentioned

PETSurfer
c3d
LAVA
Flex
FreeSurfer
NiftiReg
MATLAB

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.